Skip to main content
FERMENTA BIOTECH LIMITED logo

FERMENTA BIOTECH LIMITED — Investor Relations & Filings

Ticker · FERMENTA ISIN · INE225B01021 LEI · 335800VNTNWW8G1U9314 BSE.NS Manufacturing
Open in API
Filings indexed 671 across all filing types
Latest filing 2025-05-29 Regulatory Filings
Country IN India
Listing BSE.NS FERMENTA

About FERMENTA BIOTECH LIMITED

https://fermentabiotech.com

Fermenta Biotech Limited is a specialized biotechnology company primarily focused on the development and manufacture of Vitamin D3 (Cholecalciferol). As one of the few vertically integrated manufacturers globally, the company produces Vitamin D3 for diverse applications, including pharmaceuticals, dietary supplements, human nutrition, and animal feed. Beyond its core Vitamin D3 portfolio, the company offers a range of specialty enzymes, particularly for the synthesis of beta-lactam antibiotics, and provides environmental solutions through its biotechnology expertise. Fermenta Biotech emphasizes high-quality standards, maintaining various international certifications for its manufacturing facilities. Its product offerings extend to premixes and value-added formats designed to meet specific formulation requirements. The company serves a global clientele, leveraging its research and development capabilities to innovate in the fields of nutrition and biotechnology.

Recent filings

Filing Released Lang Actions
Annual secretarial compliance report March 31, 2025
Regulatory Filings Classification · 95% confidence The document is titled 'Annual Secretarial Compliance Report for the year ended March 31, 2025' and is issued under Regulation 24A of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It is a compliance report prepared by a practicing company secretary verifying the company's adherence to various SEBI regulations and listing obligations. The document contains detailed compliance status, observations, and confirmations related to secretarial standards and regulatory adherence, but it does not contain financial statements or management discussion of financial results. It is not an annual report, audit report, or earnings release. It is a regulatory compliance report specific to secretarial and listing obligations. This type of document fits best under the category of Regulatory Filings (RNS), as it is a regulatory compliance report that does not fall under other specific categories like Annual Report or Audit Report. The document length is substantial and contains detailed compliance information, not just an announcement or certification letter, so it is not a Report Publication Announcement or a mere certification. Therefore, the appropriate classification is Regulatory Filings (RNS).
2025-05-29 English
Press release regarding audited financial results for year ended March 31, 2025.
Earnings Release Classification · 95% confidence The document is a press release dated May 28, 2025, announcing the audited financial results for the quarter and year ended March 31, 2025. It contains detailed consolidated revenue, EBITDA, profit after tax, EPS, and segment-wise financial performance for FY25 and Q4FY25. The document includes management commentary on the results and business highlights. It is not a full annual report but a financial results announcement with key financial data and commentary. The document is longer than 5,000 characters and contains substantive financial data, so it is not a mere announcement of a report. It is not a transcript, proxy, or governance document. The content aligns with an Earnings Release (ER) as it provides initial quarterly and annual financial results highlights. FY 2025
2025-05-28 English
ESOP scheme, re-appointment of directors, appointment of secretarial auditor
Board/Management Information Classification · 95% confidence The document is a formal announcement dated May 28, 2025, addressed to the stock exchange (BSE Limited) regarding the outcome of a Board Meeting. It details several approvals by the Board of Directors, including the introduction of an Employee Stock Option Scheme, re-appointments of Executive Directors, and appointment of a Secretarial Auditor. The document references compliance with SEBI Listing Regulations and includes annexures with detailed information about the ESOP scheme and director appointments. There are no financial statements or comprehensive financial performance data included. The content focuses on corporate governance and management changes rather than financial results or reports. Therefore, this document is best classified as Board/Management Information (MANG), which covers announcements of changes in the company's board of directors or senior management.
2025-05-28 English
Annual financial results for financial year ended March 31, 2025
Regulatory Filings
2025-05-28 English
Audited financial results for FY ended March 31, 2025 and dividend
Regulatory Filings
2025-05-28 English
Fermenta Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2025 ,inter alia, to consider and approve audited financial results ....
Regulatory Filings Classification · 95% confidence The document is a notice of a forthcoming Board Meeting scheduled for May 28, 2025. It informs about the agenda items including approval of audited financial results, recommendation of final dividend, and adoption of an Employee Stock Option Scheme. It also mentions the closure of the trading window in compliance with SEBI regulations. The document is a formal announcement to the stock exchange and shareholders about the Board meeting and related compliance matters. It does not contain actual financial results, detailed reports, or transcripts. The document length is 3148 characters, which is relatively short and consistent with a meeting notice rather than a full report. Therefore, this document is best classified as a Regulatory Filing (RNS) because it is a general regulatory announcement and does not fit into more specific categories like Annual Report, Earnings Release, or Board/Management Information (which typically involves changes in personnel).
2025-05-21 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.